The New Virtual Exam Room

Your next doctor visit may be virtual. To reduce the spread of COVID-19, many doctors are opting to see patients through video calls or video conferencing. Often called telemedicine or telehealth, the concept of the virtual visit is increasing dramatically to reduce patients' need to travel or make unnecessary trips outside their home. Learn what these virtual visits are like, and how to prepare, so you can make the most of your time with your doctor. (MORE)

Footlights to Frontline

Meet Felicia Temple: R&B Singer, NET Survivor, and RN

Five years ago Felicia Temple was diagnosed with metastatic neuroendocrine cancer. Since then, she realized a lifelong dream with her rising success as a recording artist. When COVID-19 forced her to cancel a world tour, she traded sequins for scrubs. See how and why she went to the frontline as a nurse in a COVID-19 ICU. (MORE)

Coming Soon

Online Patient and Caregiver Conference

This October, NETRF is hosting a fully online NET patient and caregiver conference. We are teaming up with NET specialists at UChicago Medicine to address your questions and concerns. Mark your calendars and stay tuned for more information.

Extreme Heat Calls for Extreme Caution

Those in active cancer treatment or survivorship may face an increased risk for heat-related illness during heat waves and high humidity. Learn how to prevent and recognize heat-related illnesses to stay safe this summer. (MORE)

COVID-19 & NETs

Get up to speed on COVID-19 with a special episode of NETRF's NETWise podcast, Who faces the highest risk for serious illness? How can you tell if you are immunocompromised? Then, test your knowledge with this NET Quiz developed by LA-based patient support group LACNETS. (MORE)

Potential Prognostic NET Biomarker Identified in Published Results in NETRF-Funded Study

A retrospective analysis of neuroendocrine tumor (NET) specimens by Justin Annes, MD, PhD, Stanford University, showed that a novel test for an enzyme secreted by neuroendocrine cells may help predict the course and outcome of neuroendocrine cancers. (MORE)

Investigator Explores Novel Target in Immunotherapy

Steven K Libutti, MD, Rutgers Cancer Institute of New Jersey, is conducting laboratory experiments to characterize the role of an immune regulator called B7x (known to be present in NETs) in stopping T-cells from recognizing and killing pancreatic NET cells that can serve as the basis for the exploration of a new immunotherapy to treat pancreatic NETs. (MORE)

The CARES Act and IRA Distributions

The CARES Act, approved to offer economic relief during COVID-19, temporarily suspends mandatory distributions from IRAs for those older than 70.5 years. See how you can still realize tax benefits by using this method for charitable giving. (MORE)

Charitable Giving Trends

A recently published report evaluates giving trends in the USA for 2019. Individuals, family foundations, and corporations provide essential support for the broad range of charities, like NETRF, in the nonprofit sector. See what types of nonprofits people most commonly support and where experts expect to see changes in giving for 2020. (MORE)

This issue of NETRF's eUpdate has been sponsored in part by:

DONATE

The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

NETRF is a 501(c)(3) organization. All contributions are tax-deductible to the extent allowed by law. To learn more,
view our Audited Financial Statements and IRS Form 990.

Manage your preferences | Opt out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.

31 St. James Avenue, Suite 365
Boston, MA | 02116 US

This email was sent to .
To continue receiving our emails, add us to your address book.